ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER
树突状细胞在调节疫苗诱导的 Q 热免疫中的作用
基本信息
- 批准号:10049108
- 负责人:
- 金额:$ 12.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAerosolsAnimalsAntigen-Presenting CellsBone MarrowCD4 Positive T LymphocytesCell Differentiation processCell MaintenanceCell MaturationCellsCellular ImmunityChronicChronic DiseaseCoculture TechniquesCoxiella burnetiiDataDendritic CellsDevelopmentDiseaseEnzyme-Linked Immunosorbent AssayFlow CytometryFormalinFrequenciesGenerationsGoalsGram-Negative BacteriaHealthHumanImmuneImmune responseImmunityImmunizeIndividualInfectionInterleukin-12LipopolysaccharidesMHC Class II GenesMajor Histocompatibility ComplexMeasurableMeasuresMediatingMusOrganismOutcomes ResearchPatternPeptidesPhasePlayPreventionProductionQ FeverRiskRoleT cell differentiationT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTransgenic MiceVaccinationVaccine ProductionVaccinesVariantVirulentZoonosescytokinedesignfluin vivomouse modelnovelpathogenic microbeside effectvaccine-induced immunity
项目摘要
Abstract
Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in
humans. There is an urgent need to create a safe and effective vaccine for prevention of human Q fever.
However, the mechanisms of vaccine-induced immunity against C. burnetii natural infection remain unclear.
The long-term goal of this project is to develop a safe and effective vaccine against Q fever. The objective of
this application, which is a critical step towards this goal, is to understand the role of dendritic cells (DCs) in
regulating vaccine-induced immunity against Q fever and identify which type of T cell response is more critical
for vaccine-induced protective immunity. To achieve this objective, two specific aims were proposed to test the
central hypothesis that C. burnetii phase I vaccine (PIV) and phase II vaccine (PIIV) differentially activate
DCs, thereby promoting distinct T cell responses are responsible for the difference in their ability to confer
protection. Aim 1 will determine the role of DCs in regulating vaccine-induced immunity against Q fever by
examining i) if PIV and PIIV differentially activate DCs, thereby promoting distinct T cell differentiation patterns
in a mouse model; and ii) if DCs play a role in vaccine-induced protection against C. burnetii aerosol infection
in vivo. Aim 2 will determine the role of CD4+ T cell subsets in PIV-induced protective immunity against C.
burnetii aerosol infection by using a mouse model to investigate i) if PIV- and PIIV-induced T cell responses
are responsible for the difference in their ability to confer protection; and ii) which CD4+ subset T cell response
is more critical for PIV-induced protection. As an outcome of this research, it will gain novel information for
understanding the role of DCs in regulating T cell-mediated immunity and determining the role of T cell
responses in vaccine-induced protective immunity against C. burnetii infection. This is expected to have
significant positive effects on publich health, because it will provide critical information for developing a safe
and effective vaccine against Q fever.
抽象的
Coxiella burnetii是一种强制性细胞内革兰氏阴性细菌,会引起急性和慢性Q热。
人类。迫切需要创建一种安全有效的疫苗来预防人类Q发烧。
然而,疫苗诱导的抗牛梭菌自然感染的免疫力的机制尚不清楚。
该项目的长期目标是开发针对Q发烧的安全有效疫苗。目的
该应用是朝着这一目标迈出的关键一步,是了解树突状细胞(DC)在
调节疫苗诱导的抗Q发烧的免疫力,并确定哪种类型的T细胞反应更为关键
用于疫苗诱导的保护性免疫。为了实现这一目标,提出了两个具体目标来测试
C. burnetii I期疫苗(PIV)和II期疫苗(PIIV)差异激活的中心假设
DC,从而促进不同的T细胞响应是其授予能力差异的原因
保护。 AIM 1将确定DC在调节疫苗诱导的免疫对Q发烧的免疫力中的作用
检查i)如果PIV和PIIV差异激活DC,从而促进了不同的T细胞分化模式
在鼠标模型中; ii)如果DCS在疫苗诱导的针对C. burnetii气溶胶感染中发挥作用
体内。 AIM 2将确定CD4+ T细胞亚群在PIV诱导的针对C的保护性免疫中的作用。
使用小鼠模型研究burnetii气溶胶感染i)如果PIIV和PIIV诱导的T细胞反应
负责他们提供保护能力的差异; ii)哪个CD4+子集T细胞响应
对于PIV引起的保护更为重要。作为这项研究的结果,它将获得新的信息
了解DC在调节T细胞介导的免疫和确定T细胞的作用中的作用
疫苗诱导的保护性免疫的反应针对伯内特梭菌感染。这有望有
对Publich Health的重大积极影响,因为它将为开发安全的关键信息提供关键信息
和有效的疫苗抗Q热。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guoquan Zhang其他文献
Guoquan Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guoquan Zhang', 18)}}的其他基金
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
B-1细胞介导的伯氏柯克斯体感染免疫机制
- 批准号:
10155409 - 财政年份:2020
- 资助金额:
$ 12.48万 - 项目类别:
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII
鉴定伯内特丘克斯体的新型中和敏感表位
- 批准号:
10020119 - 财政年份:2019
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
10207396 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
10005679 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Use of a Humanized Antibody against Intracellular Bacterial Pathogen
抗细胞内细菌病原体的人源化抗体的用途
- 批准号:
10003580 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
9982219 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
9762833 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8582500 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8386914 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8197349 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
西北不同生态系统下气溶胶对边界层辐射平衡的影响及模拟研究
- 批准号:42375085
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于多源观测的北极地区有云环境气溶胶物理特性及其辐射效应研究
- 批准号:42305084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
二次有机气溶胶理化性质对其冰核性能的影响
- 批准号:42375069
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
华北地区大气气溶胶长距离输送条件下单颗粒的来源及老化机制研究
- 批准号:42307141
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants
项目1:温度和溶剂对电子烟氧化剂影响的转化研究
- 批准号:
10665896 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Diversity Supplement to Microvascular mechanisms of growth restriction after environmental toxicant exposure (R01ES031285)
环境毒物暴露后生长受限的微血管机制的多样性补充(R01ES031285)
- 批准号:
10849145 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
- 批准号:
10646631 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning
长效涕灭威水解酶作为涕灭威中毒的医学对策
- 批准号:
10724752 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10658610 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别: